An Investigation of Effectiveness and Safety of Varenicline Tartrate in Helping People Quit Smoking

NCT00371813 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 334

Last updated 2015-04-22

No results posted yet for this study

Summary

To investigate safety and efficacy of varenicline tartrate in helping people quit smoking

Conditions

  • Smoking Cessation

Interventions

DRUG

Varenicline tartrate

DRUG

Placebo

Sponsors & Collaborators

Principal Investigators

  • Pfizer CT.gov Call Center · Pfizer

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-09-30
Completion
2007-06-30

Countries

  • China
  • Singapore
  • Thailand

Study Locations

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00371813 on ClinicalTrials.gov